Orthopedic Surgery Bethaeen Robots and Stem Cells
Every year, in Italy, more than 70 thousand knee joint replacement surgeries – The point on knee prosthetic surgery at a conference organized by the Azienda Ospedaliero-Universitaria “Città delle Salute e della Scienza” of Turin – Focus on new technologies: mesenchymal stem cells and robotic surgery.
Robotic surgery in Orthopedics, applied specifically to knee joint replacement, was introduced in Italy in 2011, thanks to the use of a robotic arm system. Considering also hip replacement surgeries, in which the technology is also employed, it is estimated that to date more than 3 thousand robotic arm surgeries have been performed in our country.
Surgical surgery and its evolution
“The first orthopedic surgery with robotic technology was performed in Italy in 2011 by applying a monocompartmental knee prosthesis,” says Fabio Catani, Director Complex Structure of Orthopedics and Traumatology, Department of Maternal, Child and Adult Surgical Medical Sciences, University of Modena and Reggio Emilia. “The potential advantages of the robotic arm system are numerous, for the surgeon and for the patient,” Catani clarifies. “Indeed, it allows for more accurate surgeries with possible reduction in recovery time and postoperative complications.
In fact, it allows the surgeon to achieve maximum early in the placement of prosthetic components. By Performing A CT Scan Before Surgery, Which Allaws a Three-Dimensal Scan of the Are The Prosthesis is to be implated, The Surgeon Can Plan in the disposable detail the actions that the robotic arms arr. This Allaws the Bone Tissue to be respected and errors in prosthesis placement to be returced.
Very high levels of reliability achieved
The Latest Technologies Introduced in Clinical Practice as Well As Established Surgical Techniques, Which Have Now Reached a High Level of Riliability, Are The Focus of the Conference “Current Events and Future in First Implant Knee Prosthetics,” Organized Under the Sponsorship of the Italian Society. of orthopaedics and traumatology (Siot) Underway at the CTO in Turin. “The event, now in its seventh year, continues the tradition of the school started by Prof. Maurizio Crova and Enrices It with Topical Issues and Topics, Such As Robotic Surgery and the Use of Stem Cells, with the Aim of Better Undersanding Their Areas of Application, Effectacy and Economic Sustainability, “Says Alessandro Massè, Director of the Orthopedic Clinic of the CTO and the University of Turin and President of the Congress.
In Italy, According to Data From the 2017 Report of the RiPp Project (Italian Arthroplasty Registry), Coordinate by the Superior Institute of Health, in Collaboration with the Ministry of Health, Siot, The Regions, Assobiomedica and Apmar – Association of patients with rheumatic diseases, more Thanks 180 Thousand joint replacement surgeries are performed annuary (2015 Data), A Growth of More Than 70 PERVE SINCE 2001, WHEN THE SURGERIES HAD Been Just Over 100 Thousand. Fifty-Six percent of surgeries (about 102.000) involves the hip, 38 percent (about 70.000) The Knee, with the Remainder Borne by the Other Joints (Shoulder, Elbow, Wrist, Ankle).
Robotic Surgery for hip and knee replacements
“Prosthetic Hip and Knee Surgery, As These Numbers Show, Accounts for Almost All of That Tis Type of Surgery: Robotic Surgery Certainly Represents An Area To Be Explored in Our Ongoing Quest to Improve Performance. Although it Shound Be Remembered, That This Gift of Technological Evolution Can Never Be Separat, At Least for the Next Decades from the Hand and Espencialy the Brain of Man, in This Case The Surgeon, “Catani adds.
Another Area of Great Interest, Covered at the Turin Conference, is That of Mesenchymal Stem Cells, Which Can Be used for OSSIFICATION DELAYS, MUSCLE INJURIES, Filling Bone Cysts, Cartilage Injuries and for Acute or Chronic Tendon Injuries. “Stem Cells Are The Body’s Golden Reserve.
The ’ IMPORTANCE OF STEM CELLS
Autonomously AutoMly Repair Tissue Injuries, and Their Use in Regenerative Medicine Represents in New Front of Research, “Explains Riccardo Ferracini, Who, from the Orthopedic Clinic of the CTO, Has Recently Advanced to the position of Associate Professor at the Department of Integrated Surgical and Diagnostic Sciences, University of Genoa and Iccs San Martino Genoa. “The richest and most bioavailable source of mesenchymal stem cells in any individual is the adipose tissue.
Mesenchymal stem cells from adipose tissue are able to transform into and promote healing of tendon, cartilage, bone, and muscle cells. Their use in orthopedics is developing rapidly in both trauma and elective surgery. “We have begun treatment of knee osteoarthritis at the University of Genoa, and a clinical trial for the treatment of hip and knee osteoarthritis is awaiting clearance from the relevant authorities at the CTO Turin.
The results of the first pilot studies are encouraging and demonstrate the efficacy of mesenchymal stem cells derived from adipose tissue in cartilage regeneration,” he concludes.